2 weeks AbbVie Secures FDA Approval for Parkinson’s Disease Drug VyalevZacks

With the latest approval, ABBV’s Vyalev becomes the first and only subcutaneous 24-hour infusion of levodopa-based therapy for treating advanced Parkinson’s disease.

AbbVie (ABBV)

4 hours AbbVie (ABBV) Q3 2024 Earnings Call TranscriptThe Motley Fool X

5 hours AbbVie Trumps Q3 Earnings & Sales Estimates, Raises ’24 EPS ViewZacks X

6 hours AbbVie (NYSE:ABBV) Stock Price Up 3.2% After Dividend AnnouncementMarketBeat X

7 hours Compared to Estimates, AbbVie (ABBV) Q3 Earnings: A Look at Key MetricsZacks X

8 hours AbbVie raises 2024 profit forecast on strong sales of key drugs Skyrizi, RinvoqInvesting.com X

9 hours AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter BeatInvestor's Business Daily X

2 days Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts?Zacks X

2 days AbbVie (NYSE:ABBV) Shares Up 1.1% After Analyst UpgradeMarketBeat X

2 days First American Bank Cuts Stake in AbbVie Inc. (NYSE:ABBV)MarketBeat X

3 days Hamlin Capital Management LLC Buys 76,218 Shares of AbbVie Inc. (NYSE:ABBV)MarketBeat X

4 days Mediolanum International Funds Ltd Reduces Stock Position in AbbVie Inc. (NYSE:ABBV)MarketBeat X

5 days Final Trades: Tesla, Sweetgreen, AbbVie and Digital RealtyYouTube X

6 days AbbVie (ABBV) Outperforms Broader Market: What You Need to KnowZacks X

6 days AbbVie (NYSE:ABBV) Stock Price Up 1% – What’s Next?MarketBeat X

1 week Private Advisor Group LLC Reduces Stock Position in AbbVie Inc. (NYSE:ABBV)MarketBeat X

1 week Beat the Nasdaq With This Cash-Gushing Dividend StockThe Motley Fool X

1 week AbbVie (NYSE:ABBV) Stock Price Down 0% – Here’s What HappenedMarketBeat X

1 week Foundations Investment Advisors LLC Has $12.81 Million Position in AbbVie Inc. (NYSE:ABBV)MarketBeat X

1 week AbbVie: Strong Dividends But Humira DisappointsSeeking Alpha X

1 week The Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and SanofiZacks X

1 week AbbVie (NYSE:ABBV) Shares Down 0.5% – Time to Sell?MarketBeat X

1 week Vest Financial LLC Buys 24,610 Shares of AbbVie Inc. (NYSE:ABBV)MarketBeat X

1 week Zacks Research Comments on AbbVie’s Q3 Earnings (NYSE:ABBV)MarketBeat X

2 weeks Creative Planning Buys 40,925 Shares of AbbVie Inc. (NYSE:ABBV)MarketBeat X

2 weeks AbbVie (ABBV): Growth Driven by Skyrizi, Rinvoq, and Strategic AcquisitionsInsider Monkey X

2 weeks Bank of America Increases AbbVie (NYSE:ABBV) Price Target to $195.00MarketBeat X

2 weeks Analysts revise AbbVie stock price target ahead of earningsTheStreet X

2 weeks AbbVie (NYSE:ABBV) Trading 0.1% Higher After Analyst UpgradeMarketBeat X

2 weeks The Zacks Analyst Blog Highlights AbbVie, Automatic Data Processing, Analog Devices, Taylor Devices and Village Super MarketZacks X

2 weeks Zacks Research Weighs in on AbbVie’s Q1 Earnings (NYSE:ABBV)MarketBeat X

2 weeks Good Life Advisors LLC Boosts Stake in AbbVie Inc. (NYSE:ABBV)MarketBeat X

2 weeks Jim Cramer Says AbbVie Inc. (ABBV) ‘Is Doing Very, Very Well’Insider Monkey X

2 weeks AbbVie (ABBV) Falls More Steeply Than Broader Market: What Investors Need to KnowZacks X

2 weeks Top Stock Reports for AbbVie, ADP & Analog DevicesZacks X

2 weeks AbbVie (NYSE:ABBV) Shares Down 0.2% – Here’s WhyMarketBeat X

2 weeks Calls of the Day: Crowdstrike, Cheniere Energy, 3M, Abbott Labs, Abbvie and Eli LillyYouTube X

2 weeks AbbVie wins FDA nod for infusion treatment for advanced Parkinson’s diseaseMarketWatch X

2 weeks AbbVie (NYSE:ABBV) Given New $220.00 Price Target at BMO Capital MarketsMarketBeat X

2 weeks AbbVie (NYSE:ABBV) Earns Market Perform Rating from Analysts at Sanford C. BernsteinMarketBeat X

2 weeks Fulton Breakefield Broenniman LLC Sells 3,730 Shares of AbbVie Inc. (NYSE:ABBV)MarketBeat X

2 weeks Foster Victor Wealth Advisors LLC Boosts Stock Position in AbbVie Inc. (NYSE:ABBV)MarketBeat X

2 weeks Dividend Aristocrat AbbVie Just Paid Investors; Here’s How Much They Received24/7 Wall St. X

2 weeks CX Institutional Buys 11,227 Shares of AbbVie Inc. (NYSE:ABBV)MarketBeat X

2 weeks AbbVie Inc. (NYSE:ABBV) Sees Large Drop in Short InterestMarketBeat X

2 weeks Exchange Traded Concepts LLC Sells 96,682 Shares of AbbVie Inc. (NYSE:ABBV)MarketBeat X

2 weeks Matrix Asset Advisors Inc. NY Sells 43,986 Shares of AbbVie Inc. (NYSE:ABBV)MarketBeat X

3 weeks Livforsakringsbolaget Skandia Omsesidigt Has $21.70 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV)MarketBeat X

3 weeks AbbVie (NYSE:ABBV) Trading Up 0.1% on Analyst UpgradeMarketBeat X

3 weeks 16,116 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by Watts Gwilliam & Co. LLCMarketBeat X

3 weeks AbbVie Stock Eyes New Highs: Analysts See Strong Growth PotentialMarketBeat X